natgillin/translations-raw huggingface dataset:
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Meloksikam je nesteroidni antiinflamatorni (protuupalni) lijek (NSAIL) iz klase oksikama koji djeluje inhibirajući sintezu prostaglandina, čime se postižu antiinflamatorni, analgetski, antieksudativni i antipiretički učinci.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Meloksikam je nesteroidni protuupalni lijek (NSPUL) iz skupine oksikama čije se djelovanje temelji na inhibiciji sinteze prostaglandina, što dovodi do protuupalnog, analgetskog, antieksudativnog i antipiretičkog učinka.
Meloxicam is a Non-Steroidal Anti-Inflammatory Drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative, analgesic and antipyretic effects.
Meloksikam je nesteroidni protuupalni lijek (NSAID) iz skupine oksikama koji djeluje kočenjem sinteze prostaglandina, čime se postižu protuupalna, antieksudativna, analgetička i antipiretička svojstva.
Meloxicam is a Non-Steroidal Anti-Inflammatory Drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, anti-exudative, analgesic and antipyretic effects.
Meloksikam je nesteroidni antiinflamatorni (protuupalni) lijek (NSAIL) iz klase oksikama koji djeluje inhibirajući sintezu prostaglandina, čime se postižu antiinflamatorni, antieksudativni, analgetski i antipiretički učinci.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, anti-exudative, analgesic and antipyretic effects.
Meloksikam je nesteroidni protuupalni lijek (NSAID) iz skupine oksikama koji djeluje kočenjem sinteze prostaglandina, čime se postižu protuupalna, antieksudativna, analgetička i antipiretička svojstva.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, anti-exudative, analgesic and antipyretic effects.
Meloksikam je nesteroidni protuupalni lijek (NSPUL) iz skupine oksikama koji djeluje kočenjem sinteze prostaglandina, čime se postižu protuupalna, antieksudativna, analgetička i antipiretička svojstva.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class, which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Meloksikam je nesteroidni protuupalni lijek (NSPUL) iz klase oksikama čije se djelovanje temelji na inhibiciji sinteze prostaglandina, što dovodi do protuupalnog, analgetskog, antieksudativnog antipiretičkog učinka.
Meloxicam is completely absorbed following oral administration and maximal plasma concentrations are obtained after approximately 6.1 hours.
Meloxicam se apsorbira u potpunosti prilikom oralne primjene, a maksimalne koncentracije u plazmi postižu se nakon otprilike 6,1 sati.
Meloxicam is eliminated with a half-life of 24 hours in dogs and 15 hours in cats.
Poluživot eliminacije meloksikama je 24 sata.
Meloxicam is eliminated with a half-life of 26 hours after subcutaneous injection in young cattle.
Nakon subkutane injekcije u junadi, poluživot izlučivanja meloksikama iznosi 26 sati.
Meloxicam is eliminated with a half-life of 26 hours and 17.5 hours after subcutaneous injection in young cattle and lactating cows, respectively.
Nakon supkutane injekcije, poluživot izlučivanja meloksikama iznosi 26 sati kod mladih goveda, a 17,5 sati kod krava u razdoblju laktacije.
Meloxicam is eliminated with a terminal half-life of 7.7 hours.
Meloksikam ima terminalni poluživot eliminacije od 7,7 sati.
Meloxicam is eliminated with a terminal half-life of 7.7 hours.
Meloksikam se eliminira s konačnim poluživotom od 7,7 sati.
Meloxicam is eliminated with a terminal half-life of 7.7 hours.
Terminalni poluživot izlučivanja meloksikama iznosi 7,7 sati.
Meloxicam is metabolised to an alcohol, an acid derivative and to several polar metabolites.
Meloksikam metabolizira na alkohol, kisele derivate te na više polarnih metabolita.
Meloxicam is metabolised to an alcohol, an acid derivative and to several polar metabolites.
Meloksikam metabolizira u alkohol, kisele derivate te više polarinih metabolita.
Meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Meloksikam se pretežno nalazi u plazmi i izlučuje se uglavnom izlučuje preko žuči, dok se u mokraći nalaze samo tragovi ishodišnog spoja.
Meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Meloksikam se pretežno nalazi u plazmi, a izlučuje se uglavnom preko žuči, dok mokraća sadrži samo tragove ishodišnog spoja.
Meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Meloksikam se pretežno nađe u plazmi a izlučuje se uglavnom preko žuči, dok mokraća sadrži samo tragove ishodišnog spoja.
Meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Meloksikam se pretežno nađe u plazmi, a izlučuje se uglavnom preko žuči, dok mokraća sadrži samo tragove ishodišnog spoja.
Meloxicam may be harmful for the foetus and unborn child.
Meloksikam može biti štetan fetusu i nerođenom djetetu.
Meloxicam: 0.5 mg/ml Sodium Benzoate: 1.5 mg/ml
Meloksikam: 0,5 mg/ml Natrijev benzoat: 1,5 mg/ml
Meloxicam: 5 mg/ml
Meloksikam 5 mg/ml
Meloxicam: 5 mg/ml,
Meloksikam 5 mg/ml
Meloxicam: 5 mg/ml,
Meloksikam: 5 mg/ml
Meloxicam: 5 mg/ml,
Meloksikam: 5 mg/ml,
Meloxidolor 20 mg/ml solution for injection for cattle, pigs and horses Meloxicam
Meloxidolor 20 mg/ml otopina za injekcije za goveda, svinje i konje Meloksikam
Meloxidolor 5 mg/ml solution for injection for dogs, cats, cattle and pigs Meloxicam
Meloxidolor 5 mg/ml otopina za injekcije za pse, mačke, goveda i svinje Meloksikam
Meloxidolor alone will not provide adequate pain relief during the dehorning procedure.
Ako se primjenjuje sam, Meloxidolor neće dovoljno smanjiti bolove za vrijeme postupka odroţnjavanja.
Meloxidyl 0.5 mg/ml
Ceva Santé Animale
Meloxidyl 0.5 mg/ml oral suspension for cats
Meloxidyl 0.5 mg / ml, peroralna suspenzija za mačke
Meloxidyl 0.5 mg/ml oral suspension for cats 15 & 5 ml
Meloxidyl 0.5 mg/mL peroralna otopina za mačke 15 ml i 5 ml
Meloxidyl 0.5 mg/ml oral suspension for cats Meloxicam
Meloxidyl 0.5 mg/ml peroralna suspenzija za mačke Meloksikam.
Meloxidyl 1.5 mg/ml
Ceva Santé Animale
Meloxidyl 1.5 mg/ml oral suspension for dogs may be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg body weight, 24 hours after administration of the injection.
U nastavku liječenja može se koristiti Meloxidyl 1.5 mg /ml peroralna suspenzija za pse u dozi od mg meloksikama / kg tjelesne mase, 24 sata po davanju injekcije.
Meloxidyl 1.5 mg/ml oral suspension for dogs.
Meloxidyl 1.5 mg / ml peroralna suspenzija za pse.
Meloxidyl 1.5 mg/ml oral suspension for dogs.
Meloxidyl 1.5 mg / ml, peroralna suspenzija za pse.
Meloxidyl 1.5 mg/ml oral suspension for dogs.
Meloxidyl 1.5 mg/ml, peroralna suspenzija za pse
Meloxidyl 1.5 mg/ml oral suspension may be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg body weight, 24 hours after administration of the injection.
U nastavku liječenja može se koristiti Meloxidyl 1.5 mg / ml peroralna suspenzija u dozi od 0.1 mg meloksikama / kg tjelesne mase, 24 sata nakon davanja injekcije.
Meloxidyl 20 mg/ml
Ceva Santé Animale
Meloxidyl 20 mg/ml solution for injection for cattle, pigs and horses
Meloxidyl 20 mg / ml, injekcijska otopina za goveda svinje i konje
Meloxidyl 20 mg/ml solution for injection for cattle, pigs, horses 50, 100, & 250 ml
Meloxidyl 20 mg / ml, injekcijska otopina za goveda svinje i konje 50 ml, 100 ml i 250 ml
Meloxidyl 20 mg/ml solution for injection for cattle, pigs, horses Meloxicam
Meloxidyl 20 mg / ml, injekcijska otopina za goveda svinje i konje Meloksikam.
Meloxidyl 5 mg/ml
Ceva Santé Animale
Meloxidyl 5 mg/ml solution for injection for dogs and cats
Meloxidyl 5 mg / ml, injekcijska otopina za pse i mačke
Meloxidyl 5 mg/ml solution for injection for dogs, cats 10 ml
Meloxidyl 5 mg / ml, injekcijska otopina za pse i mačke 10 ml
Meloxidyl 5 mg/ml solution for injection for dogs, cats Meloxicam
Meloxidyl 5 mg / ml injekcijska otopina za pse i mačke Meloksikam.
Meloxidyl alone will not provide adequate pain relief during dehorning procedure.
Ako se primjenjuje sam, Meloxidyl neće dovoljno smanjiti bolove za vrijeme postupka odroţnjavanja.
Meloxidyl must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Ovaj pripravak ne smije se primjenjivati istodobno s drugim NSPUL ili glukokortikosteroidima.
Meloxidyl® must not be administered in conjunction with other NSAIDs or glucocortisosteroids.
Meloxidyl® se ne smije primjenjivati istodobno s drugim NSPUL ili glukokortikosteroidima.
Meloxidyl®must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Meloxydil se ne smije primjenjivati istodobno s drugim NSPUL ili glukokortikosteroidima.
Meloxivet 0.5 mg/ml oral suspension for dogs
Meloxivet 0,5 mg/ml oralna suspenzija za pse
Meloxivet 1.5 mg/ml oral suspension for dogs
Meloxivet 1,5 mg/ml oralna suspenzija za pse
Meloxoral 1.5 mg/ml oral suspension for dogs
Meloxoral 1,5 mg/ml oralna suspenzija za pse
Meloxoral must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Meloxoral se ne smije primjenjivati zajedno s drugim nesteroidnim protuupalnim lijekovima (NSPUL) ili glukokortikosteroidima.
Melphalan (9 mg/m2) and prednisone (60 mg/m2) are both given orally on days 1, 2, 3 and 4 of the first week of each cycle.
Melfalan (9 mg/m2) i prednizon (60 mg/m2) primjenjuju se kroz usta i daju se na 1., 2., 3. i 4. dan prvog tjedna primjene tijekom svih ciklusa.
Melphalan and prednisone should both be given orally on days 1, 2, 3 and 4 of the first week of each Bortezomib Accord treatment cycle.
Melfalan i prednizon trebaju se primijeniti oralno 1., 2., 3. i 4. dan prvog tjedna svakog ciklusa liječenja Bortezomib Accordom.
Melphalan and prednisone should both be given orally on days 1, 2, 3 and 4 of the first week of each VELCADE treatment cycle.
Melfalan i prednizon trebaju se primijeniti oralno 1., 2., 3. i 4. dan prvog tjedna svakog ciklusa liječenja VELCADEom.
Melphalanc,d,e
Melfalanc,d,e
MEM without phenol red Sodium bicarbonate Hepes acid
MEM bez fenol crvene Natrij bikarbonat Hepes kiselina
Memantine Accord 10 mg film-coated tablets Memantine hydrochloride
Memantin Accord 10 mg filmom obložene tablete memantinklorid
Memantine Accord 10mg film-coated tablets are presented as white, oblong, coated and scored tablet, debossed with “MT” divided by the score on one side and “10” divided by the score on the other side.
Memantin Accord 10 mg filmom obložene tablete su bijele, duguljaste, filmom obložene tablete, s razdjelnom crtom između utisnute oznake “MT” na jednoj strani i razdjelnom crtom između utisnute oznake “10” na drugoj strani.
Memantine Accord 10mg film-coated tablets Memantine hydrochloride
Memantin Accord 10 mg filmom obložene tablete memantinklorid
Memantine Accord 15mg film-coated tablets are presented as orange to grey-orange, oblong, coated tablet, debossed with “MT” on one side and “15” on the other side.
Memantin Accord 15 mg filmom obložene tablete su narančaste do sivo-narančaste, duguljaste, obložene tablete, s utisnutom oznakom ‘MT’ na jednoj strani i ‘15’ na drugoj strani.
Memantine Accord 20 mg film-coated tablets Memantine hydrochloride
Memantin Accord 20 mg filmom obložene tablete memantinklorid
Memantine Accord 20mg film-coated tablets are presented as pale red to greyred, oblong, coated and scored tablet, debossed with “MT” divided by the score on one side and “20” divided by the score on the other side.
Memantin Accord 20 mg filmom obložene tablete su blijedocrvene do sivo-crvene, duguljaste, obložene tablete, s razdjelnom crtom između utisnute oznake ‘MT’ na jednoj strani i razdjelnom oznakom između utisnute oznake ‘20’ na drugoj strani.
Memantine Accord 5 mg film-coated tablets Memantine Accord 10 mg film-coated tablets Memantine Accord 15 mg film-coated tablets Memantine Accord 20 mg film-coated tablets Memantine hydrochloride
Memantin Accord 5 mg filmom obložene tablete Memantin Accord 10 mg filmom obložene tablete Memantin Accord 15 mg filmom obložene tablete Memantin Accord 20 mg filmom obložene tablete memantinklorid
Memantine Accord 5 mg film-coated tablets Memantine Accord 10mg film-coated tablets Memantine Accord 15mg film-coated tablets Memantine Accord 20mg film-coated tablets Memantine hydrochloride
Memantin Accord 5 mg filmom obložene tablete Memantin Accord 10 mg filmom obložene tablete Memantin Accord 15 mg filmom obložene tablete Memantin Accord 20 mg filmom obložene tablete memantinklorid
Memantine Accord 5mg film-coated tablets are presented as white, oblong, coated tablet, debossed with “MT” on one side and “5” on the other side.
Memantin Accord 5 mg filmom obložene tablete su bijele, duguljaste, obložene tablete, s utisnutom oznakom ‘MT’ na jednoj strani i ‘5’ na drugoj strani.
Memantine Accord film-coated tablets are presented as pale red to greyred, oblong, coated and scored tablet, debossed with "MT" divided by the score on one side and “20” divided by the score on the other side.
Memantin Accord filmom obložene tablete su blijedocrvene do sivo-crvene, duguljaste, obložene tablete, s razdjelnom crtom između utisnute oznake ‘MT’ na jednoj strani te s razdjelnom crtom između utisnute oznake ‘20’ na drugoj strani.
Memantine Accord is a ‘generic medicine’.
Memantine Accord je „generički lijek”.
Memantine Accord is not recommended for children and adolescents under the age of 18years.
Memantin Accord se ne preporučuje za djecu i adolescente mlađe od 18 godina.
Memantine Accord should be administered once a day and should be taken at the same time every day.
Memantin Accord treba primjenjivati jednom dnevno i potrebno ga je uzimati svaki dan u isto vrijeme.
Memantine Accordfilm-coated tablets are available in blister packs (PVC/PE/PVDC-aluminium blister) of 14 tablets, 28 tablets, 30tablets, 42 tablets, 50tablets, 56tablets, 98 tablets, 100tablets and 112tablets.
Memantin Accord filmom obložene tablete dostupne su u pakiranjima s blisterima (PVC/PE/PVDC- aluminijski blister) 14 tableta, 28 tableta, 30 tableta, 42 tablete, 50 tableta, 56 tableta, 98 tableta, 100 tableta i 112 tableta.
Memantine Accordfilm-coated tablets are available in blister packs (PVC/PE/PVDC-aluminium blister) of 14 tablets, 28tablets, 42tablets, 56tablets and 98tablets.
Memantin Accord filmom obložene tablete su dostupne u pakiranjima s blisterima (PVC/PE/PVDC- aluminijski blister) od 14 tableta, 28 tableta, 42 tablete, 56 tableta i 98 tableta.
Memantine Accordis used for the treatment of patients with moderate to severe Alzheimer’s disease.
Memantin Accord se koristi za liječenje bolesnika s umjerenom do teškom Alzheimerovom bolešću.
Memantine did not inhibit CYP 1A2, 2A6, 2C9, 2D6, 2E1, 3A, flavin containing monooxygenase, epoxide hydrolase or sulphationin vitro.
Memantin nije in vitro inhibirao CYP 1A2, 2A6, 2C9, 2D6, 2E1, 3A, monooksigenazu koja sadržava flavin, epoksid hidrolazu niti sulfaciju.
Memantine hydrochloride Week 1, Day 1 2 3 4 5 6 7
1. tjedan, 1., 2., 3., 4., 5., 6., 7. dan
Memantine LEK 10 mg film-coated tablets are available in PVC/PVDC–Aluminium blister packs of 28, 30, 42, 50, 56, 60, 98, 100 and 112 tablets.
Memantine Lek 10 mg filmom obložene tablete su dostupne u PVC/PVDC-aluminij blister pakiranju sa 28, 30, 42, 50, 56, 60, 98, 100 i 112 tableta.
Memantine LEK 10 mg film-coated tablets are presented as yellow, oval film-coated tablet scored in one side.
Memantine LEK 10 mg filmom obložene tablete su žute boje, ovalnog oblika, urezane na jednoj strani.
Memantine LEK 10 mg film-coated tablets Memantine hydrochloride
Memantine LEK 10 mg filmom obložene tablete memantinklorid
Memantine LEK 10 mg film-coated tablets Memantine LEK 20 mg film-coated tablets Memantine hydrochloride
Memantine LEK 10 mg filmom obložene tablete Memantine LEK 20 mg filmom obložene tablete memantinklorid
Memantine LEK 10 mg film-coated tablets.
Memantine LEK 10 mg filmom obložene tablete
Memantine LEK 20 mg film-coated tablets are available in PVC/PVDC–Aluminium blister packs of 28, 30, 42, 56, 98 and 100 tablets.
Memantine Lek 20 mg filmom obložene tablete su dostupne u PVC/PVDC-aluminij blister pakiranju sa 28, 30, 42, 56, 98 i 100 tableta.
Memantine LEK 20 mg film-coated tablets Memantine hydrochloride
Memantine LEK 20 mg filmom obložene tablete memantinklorid
Memantine LEK 20 mg film-coated tablets.
Memantine LEK 20 mg filmom obložene tablete
Memantine LEK belongs to a group of medicines called NMDA receptor antagonists.
Memantine LEK spada u skupinu lijekova poznatih kao antagonisti NMDA receptora.
Memantine LEK is not recommended for children and adolescents under the age of 18 years.
Memantine LEK se ne preporučuje za djecu i adolescente mlađe od 18 godina.
Memantine LEK is not recommended for use in children and adolescents below 18 years due to a lack of data on safety and efficacy.
Primjena lijeka Memantine LEK kod djece mlađe od 18 godina se ne preporučuje zbog nedostatka podataka o sigurnosti i djelotvornosti.
Memantine LEK is used for the treatment of patients with moderate to severe Alzheimer’s disease.
Memantine LEK se koristi za liječenje bolesnika s umjerenom do teškom Alzheimerovom bolešću.
Memantine Merz 10 mg film-coated tablets.
Memantine Merz 10 mg filmom obložene tablete.
Memantine Merz 15 mg film-coated tablets are presented as orange to grey-orange, oval-oblong with imprint ‘15’ on one side and imprint ‘MEM’ on the other side.
Memantine Merz 15 mg filmom obložene tablete su narančaste do sivo-narančaste, ovalno duguljaste s utisnutom oznakom ‘15’ na jednoj strani i ‘MEM’ na drugoj strani.
Memantine Merz 15 mg film-coated tablets.
Memantine Merz 15 mg filmom obložene tablete.
Memantine Merz 20 mg film-coated tablets are presented as are pale red to grey-red, oval-oblong with imprint ‘20’ on one side and imprint ‘MEM’ on the other side.
Memantine Merz 20 mg filmom obložene tablete su blijedocrvene do sivo-crvene, ovalno duguljaste s utisnutom oznakom ‘20’ na jednoj strani i ‘MEM’ na drugoj strani.
Memantine Merz 20 mg film-coated tablets.
Memantine Merz 20 mg filmom obložene tablete
Memantine Merz 20 mg film-coated tablets.
Memantine Merz 20 mg filmom obložene tablete.
Memantine Merz 5 mg film-coated tablets are presented as white to off-white, oval-oblong with imprint ‘5’ on one side and imprint ‘MEM’ on the other side.
Memantine Merz 5 mg filmom obložene tablete su bijele do gotovo bijele, ovalno duguljaste s utisnutom oznakom ‘5’ na jednoj strani i ‘MEM’ na drugoj strani.
Memantine Merz 5 mg film-coated tablets.
Memantine Merz 5 mg filmom obložene tablete.
Memantine Merz 5mg, 10mg, 15mg, 20 mg film-coated tablets Memantine hydrochloride
Memantine Merz 5mg, 10 mg, 15mg, 20mg filmom obložene tablete memantinklorid
Memantine Merz 5mg, Memantine Merz 10 mg Memantine Merz 15 mg Memantine Merz 20 mg film-coated tablets
Memantine Merz 5 mg, Memantine Merz 10 mg Memantine Merz 15 mg Memantine Merz 20 mg filmom obložene tablete
Memantine Merz 5mg/pump actuation, oral solution.
Memantine Merz 5 mg/potisak, oralna otopina.
Memantine Merz belongs to a group of medicines called NMDA-receptor antagonists.
Memantine Merz spada u skupinu lijekova poznatih kao antagonisti NMDA receptora.
Memantine Merz film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 42 tablets, 56 tablets, 98 tablets or in multipacks of 840 (20 x 42) tablets
Memantine Merz filmom obložene tablete su dostupne u pakiranjima s blisterima od 14 tableta, 28 tableta, 42 tablete, 56 tableta, 98 tableta i višestrukim pakiranjima od 840 (20 pakiranja od 42) tableta.
Memantine Merz film-coated tablets are presented as pale red to grey-red, oval-oblong film-coated tablets with imprint ‘20’ on one side and imprint ‘MEM’ on the other side.
Memantine Merz filmom obložene tablete su blijedocrvene do sivo-crvene, ovalno duguljaste filmom obložene tablete s utisnutom oznakom ‘20’ na jednoj strani i ‘MEM’ na drugoj strani.
Memantine Merz film-coated tablets are presented as pale yellow to yellow, oval shaped film-coated tablet with breaking line and engravings "1-0" on one side and "M M" on the other side
Memantine Merz filmom obložene tablete su blijedožute do žute boje, filmom obložene tablete ovalnog oblika s razdjelom crtom i utisnutim oznakama “1-0” na jednoj strani te “M M” na drugoj strani.
Memantine Merz is not recommended for children and adolescents under the age of 18 years.
Memantine Merz se ne preporučuje za djecu i adolescente mlađe od 18 godina.
Memantine Merz is used for the treatment of patients with moderate to severe Alzheimer’s disease.
Memantine Merz se koristi za liječenje bolesnika s umjerenom do teškom Alzheimerovom bolešću.
Memantine Merz oral solution is available in bottles of 50 ml, 100 ml or a multipack of 500ml (10 x 50 ml).
Memantine Merz oralna otopina dostupna je u bocama od 50 ml, 100 ml ili višestruko pakiranje od 500ml (10 x 50 ml).
Memantine Merz should be administered once a day and should be taken at the same time every day.
Memantine Merz se mora primjenjivati jednom dnevno i potrebno ju je uzimati svaki dan u isto vrijeme.
Memantine Merz should be taken once daily at the same time each day.
Memantine Merz se mora uzimati jednom dnevno, svaki dan u isto vrijeme.
Memantine Merz with food and drink
Uzimanje hrane i pića s Memantine Merz s hranom i, pićem
Memantine Mylan 10 mg film-coated tablets
Memantine Mylan 10 mg filmom obložene tablete
Memantine Mylan 10 mg film-coated tablets memantine hydrochloride
Memantine Mylan 10 mg filmom obložene tablete memantinklorid
Memantine Mylan 20 mg film-coated tablets
Memantine Mylan 20 mg filmom obložene tablete
Memantine Mylan 20 mg film-coated tablets memantine hydrochloride
Memantine Mylan 20 mg filmom obložene tablete memantinklorid
Memantine Mylan acts on these NMDA-receptors improving the transmission of nerve signals and the memory.
Memantine Mylan djeluje na navedene NMDA receptore poboljšavajući prijenos živčanih signala i pamćenje.
Memantine Mylan belongs to a group of medicines called NMDA- receptor antagonists.
Memantine Mylan spada u skupinu lijekova poznatih kao antagonisti NMDA receptora.
Memantine Mylan contains the active substance memantine.
Memantine Mylan sadrži djelatnu tvar memantin.
Memantine Mylan is not recommended for children and adolescents under the age of 18 years.
Memantine Mylan se ne preporučuje za djecu i adolescente mlađe od 18 godina.
Memantine Mylan is used for the treatment of patients with moderate to severe Alzheimer’s disease.
Memantine Mylan se koristi za liječenje bolesnika s umjerenom do teškom Alzheimerovom bolešću.
Memantine Mylan should be administered orally once a day and should be taken at the same time every day.
Memantine Mylan treba primjenjivati oralno jednom dnevno i potrebno ju je uzimati svaki dan u isto vrijeme.
Memantine Mylan should be administered orally once a day.
Memantine Mylan treba primjenjivati na usta jedanput na dan.
Memantine Mylan with food and drink
Memantine Mylan s hranom i pićem
Memantine ratiopharm 10 mg film-coated tablets
Memantin ratiopharm 10 mg filmom obložene tablete
Memantine ratiopharm 10 mg film-coated tablets Memantine hydrochloride
Memantin ratiopharm 10 mg filmom obložene tablete memantinklorid
Memantine ratiopharm 10 mg tablets Memantine hydrochloride
Memantin ratiopharm 10 mg tablete memantinklorid
Memantine ratiopharm 15 mg film-coated tablets Memantine hydrochloride
Memantin ratiopharm 15 mg filmom obložene tablete memantinklorid